ENATRANS was established to support the translation of innovative projects in nanomedicine across different development stages – from the idea to the patient – and to expand knowledge on nanomedicine.
ENATRANS’ cornerstone is the Translation Advisory Board (TAB), a newly created instrument that allows ambitious European projects on nanomedicine to receive free advice and assistance by first-class, recognised experts from the industrial sector.
VDI/VDE-IT coordinates the seven partners from France, Portugal, Israel, Italy and Germany.
VDI/VDE-IT coordinates the ENATRANS project and, in this role, supervises processes for the smooth execution of the project. It also represents the project in the European Commission and before external stakeholders. In addition, VDI/VDE-IT is strongly involved in networking and dissemination activities.
